Literature DB >> 2040384

Multifactorial origin of hypoglycemic symptom unawareness in IDDM. Association with defective glucose counterregulation and better glycemic control.

W L Clarke1, L A Gonder-Frederick, F E Richards, P E Cryer.   

Abstract

To assess potential relationships between unawareness of hypoglycemic symptoms and both defective glucose counterregulation and therapy-associated altered glycemic thresholds, symptoms and hormonal responses to hypoglycemia were quantitated during standardized insulin infusion tests in 41 patients with insulin-dependent diabetes mellitus (IDDM). The glycemic thresholds for both neurogenic and neuroglycopenic symptoms (and those for both epinephrine and pancreatic polypeptide release) were at lower plasma glucose concentrations in both patients with defective (n = 9, 22%) and those with adequate glucose counterregulation and, among the latter, in patients with lower compared with higher glycosylated hemoglobin levels. The data are consistent with the concept that both defective glucose counterregulation and improved glycemic control contribute to excessive hypoglycemia in IDDM by reducing awareness of symptoms of developing hypoglycemia and by impairing physiological defenses against hypoglycemia. Thus, hypoglycemic symptom unawareness is multifactorial in origin and may be partly reversible.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2040384     DOI: 10.2337/diab.40.6.680

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

Review 1.  [Hypoglycemia, classification, therapy and preventable errors].

Authors:  R Lobmann; H Lehnert
Journal:  Internist (Berl)       Date:  2003-10       Impact factor: 0.743

2.  Orexin signaling is necessary for hypoglycemia-induced prevention of conditioned place preference.

Authors:  Oleg Otlivanchik; Nicole M Sanders; Ambrose Dunn-Meynell; Barry E Levin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-10-28       Impact factor: 3.619

3.  Differential changes in brain glucose metabolism during hypoglycaemia accompany loss of hypoglycaemia awareness in men with type 1 diabetes mellitus. An [11C]-3-O-methyl-D-glucose PET study.

Authors:  E M Bingham; J T Dunn; D Smith; J Sutcliffe-Goulden; L J Reed; P K Marsden; S A Amiel
Journal:  Diabetologia       Date:  2005-09-06       Impact factor: 10.122

4.  The Glu23Lys polymorphism in KCNJ11 and impaired hypoglycaemia awareness in patients with type 1 diabetes.

Authors:  Andreas Holstein; Armin Plaschke; Michael Stumvoll; Peter Kovacs
Journal:  J Hum Genet       Date:  2005-09-02       Impact factor: 3.172

5.  Pubertal stage and hypoglycaemia counterregulation in type 1 diabetes.

Authors:  L A Ross; R E Warren; C J H Kelnar; B M Frier
Journal:  Arch Dis Child       Date:  2005-02       Impact factor: 3.791

Review 6.  Islet cell transplantation.

Authors:  P Srinivasan; G C Huang; S A Amiel; N D Heaton
Journal:  Postgrad Med J       Date:  2007-04       Impact factor: 2.401

7.  Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM.

Authors:  C Fanelli; S Pampanelli; L Epifano; A M Rambotti; A Di Vincenzo; F Modarelli; M Ciofetta; M Lepore; B Annibale; E Torlone
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

8.  Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia.

Authors:  S E Dagogo-Jack; S Craft; P E Cryer
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

Review 9.  Hypoglycemia in patients with type 1 diabetes: epidemiology, pathogenesis, and prevention.

Authors:  Omodele Awoniyi; Rabia Rehman; Samuel Dagogo-Jack
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

10.  Hypoglycemia unawareness in a patient with dumping syndrome: report of a case.

Authors:  F Bellini; L Sammicheli; L Ianni; C Pupilli; M Serio; M Mannelli
Journal:  J Endocrinol Invest       Date:  1998 Jul-Aug       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.